Sort
40,608 grants matching “prostate cancer”
Reagents for the Design of Targeted Multifunctional Nanomaterials
$378,479Lee Josephson · Massachusetts General Hospital · R01 · FY2012 · EB
Minority-Based CCOP at UMDNJ-NJ Medical School/University Hospital Cancer Center
$378,466Robert Wieder · Rbhs-New Jersey Medical School · U10 · FY2014 · CA
Mechanism of PIN development in Abi1/Hssh3bp1 KO mouse
$378,420Leszek Kotula · Upstate Medical University · R01 · FY2017 · CA
A Phase I/II Clinical Trial of Intravenous (I.V.) Calcitriol with Fixed Doses of
$378,381Nithya Ramnath · University Of Michigan At Ann Arbor · R21 · FY2009 · CA
Telomerase RNA Transfected Dendritic Cell Vaccines
$378,363Duke University · R01 · FY2002 · CA
STUDY OF THE ROLE OF EZH2 IN THE REGULATION OF MACROPHAGE POLARIZATION IN PROSTATE CANCER TUMORAL MICROENVIRONMENT
$378,336The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. · · FY2025 · Defense Health Agency
Community Outreach and Engagement
$378,301Moon S Chen · University Of California At Davis · P30 · FY2023 · CA
Controlled Release of Macromolecules
$378,300Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2014 · EB
TRD 1 - Imaging Cancer Heterogeneity
$378,277Nathalie Yr Agar · Brigham And Women'S Hospital · P41 · FY2025 · EB
Glucocorticoids & Vitamin D: Role In Anti-Tumor Effects
$378,257Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
Neural Mechanisms of Cancer Pain
$378,229Donald A Simone · University Of Minnesota · R01 · FY2021 · CA
Cell-Surface Interactions in Pathogenesis
$378,203Kenneth Yamada · National Institute Of Dental & Craniofacial Research · ZIA · FY2014 · DE
Leveraging the methionine salvage pathway as a novel therapy for prostate cancer.
$378,193Dominic James Smiraglia · Roswell Park Cancer Institute Corp · R01 · FY2020 · CA
Early Cancer Detection & Prognosis through Glycomics
$378,186Milos V Novotny · Trustees Of Indiana University · U01 · FY2010 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$378,165Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2022 · CA
Trk Expression and Inhibition in Human Neuroblastomas
$378,136Garrett M Brodeur · Children'S Hosp Of Philadelphia · R01 · FY2009 · CA
P13K/PTEN/Akt signaling and the genesis of cancer
$378,132Nissim Hay · University Of Illinois At Chicago · R01 · FY2009 · CA
Targeting the MLL complex in Castration Resistant Prostate Cancer
$378,124Jolanta Grembecka · University Of Michigan At Ann Arbor · R01 · FY2018 · CA
Functional Significance of Prostate Cancer risk-SNPs
$378,095Stephen Norman Thibodeau · Mayo Clinic Rochester · R01 · FY2011 · CA
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
$378,088Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2014 · CA
DNA Polymerase B and Cell Transformation
$378,066Joann B Sweasy · Yale University · P01 · FY2008 · CA
TOWARD UNDERSTANDING THE ROLE OF TMPRSS2-ERG VARIANTS IN PROSTATE CANCER PROGRESSION
$378,000Weill Medical College Of Cornell University · · FY2009 · Department of the Army
Tumor-expressed immune checkpoint B7x-mediated resistance to anti-CTLA-4 therapy.
$378,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2022 · CA
The B7x pathways in the tumor microenvironment
$378,000Xingxing Zang · Albert Einstein College Of Medicine · R01 · FY2024 · CA
ANALYSIS OF PTEN HAPLOINSUFFICIENCY AND SENESCENE RESPONSES IN HUMAN PROSTATE CANCER
$378,000Cold Spring Harbor Laboratory · · FY2009 · Department of the Army